Skip to search formSkip to main contentSkip to account menu

Vivitrol

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Naltrexone
Naltrexone 380 MG Injection [Vivitrol]Naltrexone Injection [Vivitrol]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials
Abstract Introduction: Amfetamine and methamfetamine abuse remains a prevalent health problem, increasing the burden on… 
2018
2018
[The efficiency of the medical rehabilitation program with the use of injectable naltrexone for alcohol addicted patients who are at risk of parental rights deprivation].
AIM To evaluate the efficacy of treatment of patients at risk of deprivation of parental rights due to alcohol dependence under… 
2015
2015
A needs comparison of justice-involved Iraq/Afghanistan veterans to other service eras
2015
2015
The Vivitrol pilot program (VPP): initial quantitative findings from an extended-release naltrexone study
Background In 2010, the FDA approved the use of extended-release injectable naltrexone (Vivitrol©) for the treatment of opioid… 
2014
2014
Influence of Microencapsulation Process Parameters on Naltrexone Prolonged-Release Dosage Form
The quality parameters of naltrexone microspheres based on the copolymer of lactic and glycolic acids (PLGA) were established as… 
2013
2013
[Characteristics of the formation, course and treatment of alcohol dependence in patients with posttraumatic stress disorder].
This article presents the results of a study of clinical features of the development and course of alcohol dependence in patients… 
2011
2011
Gates eyes biotechs as for-profit investments
2011
2011
Alkermes, Elan in $960 million merger
In May, the drugdelivery specialist Alkermes announced it would merge with Elan Drug Technologies (EDT), the chemical formulation… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)